Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Scientific Reports|April 2, 2026
A randomized comparison of etoposide and cyclophosphamide for stem cell mobilization in newly diagnosed multiple myelomaYao Sun, Jieping Li, Yujun Dong, et al.
Scientific Reports|October 1, 2016
High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemiaLin Fu, Huaping Fu, Lei Zhou, et al.
Plos One|November 22, 2014
Susceptibility of Ph-positive all to TKI therapy associated with Bcr-Abl rearrangement patterns: a retrospective analysisYu Jing, Huiren Chen, Mingjuan Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamidesZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2025
Favorable impact of zanubrutinib combined with R-CHOP regimen in MYD88-mutated new-diagnosed diffuse large B-cell lymphoma: a retrospective study with propensity score-matched analysisXiubin Xiao, Shunzong Yuan, Xilin Chen, et al.
The FEBS Journal|December 10, 2013
AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemiaLin Fu, Wenrong Huang, Yu Jing, et al.
Oncotarget|October 4, 2017
Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studiesZhenyang Gu, Li Wang, Lei Yuan, et al.
Annals of Transplantation|June 23, 2018
T Cell-Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation for Treatment of T-Lymphoblastic LymphomaLixun Guan, Xiaohong Li, Huaping Wei, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 2: A survey of P4 motifsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitorsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Pageof 7